2024-09-18 - Analysis Report
## CVS Health Corporation Stock Analysis

**Company Overview:** CVS Health Corporation is a healthcare company that operates retail pharmacies, pharmacy benefit management (PBM) services, and healthcare services. 

**1. Performance Comparison with S&P 500:**

CVS has underperformed the S&P 500 (VOO) significantly, with a cumulative return of -20.03% compared to 89.02% for VOO. The current divergence is -109.05%, indicating that CVS has performed much worse than the S&P 500. This is further evidenced by the relative divergence of 1.44, indicating that the current divergence is relatively close to its historical minimum. 

**2. Recent Price Action:**

CVS's recent price action suggests a slight bullish trend. The closing price of $58.37 is above the 5-day moving average ($57.39), 20-day moving average ($57.8), and slightly below the 60-day moving average ($58.43). 

**3. Technical Indicators:**

* **RSI:** The RSI of 48.42 suggests that CVS is currently trading in neutral territory, neither overbought nor oversold.
* **PPO:** The PPO of 0.15 indicates that the price momentum is slightly positive, suggesting potential for continued upward movement.
* **Delta_Previous_Relative_Divergence:** The negative value (-1.82) suggests a recent decrease in relative performance, indicating potential short-term downward pressure.
* **Expected_Return:** The expected return of 12.44% represents the potential maximum 5-year return based on current investment. This is a positive indicator for long-term investors.

**4. Recent Earnings and Outlook:**

CVS's recent earnings have been mixed. While the company has consistently surpassed earnings estimates, its growth rate has been declining. 

| Date | EPS | Expected EPS |
|---|---|---|
| 2024-08-07 | 1.83 | 1.73 |
| 2024-05-01 | 1.31 | 1.7 |
| 2024-02-07 | 2.12 | 2.01 |
| 2023-11-01 | 2.21 | 2.13 |
| 2023-08-02 | 2.21 | 2.12 |

The most recent earnings report shows that CVS exceeded expectations with an EPS of 1.83 compared to an expected EPS of 1.73. However, the growth rate has slowed down compared to the previous quarter.

**5. Summary:**

CVS is currently facing challenges with its stock performance lagging significantly behind the S&P 500. Despite some positive signs in recent price action and technical indicators, the company's recent earnings have been mixed, with a declining growth rate.  Investors should monitor CVS's future performance closely to assess its long-term growth potential. 

**6. Key Takeaways for Investors:**

* CVS has underperformed the broader market significantly.
* While recent price action suggests potential for a short-term uptrend, technical indicators are mixed, indicating a neutral outlook.
* Earnings growth has been slowing, although CVS consistently exceeds expectations. 
* Investors should monitor CVS's future performance and earnings releases to determine if the company can improve its growth trajectory.

**Disclaimer:** This analysis is for informational purposes only and should not be considered investment advice. It is essential to conduct thorough research and consult with a financial advisor before making any investment decisions. 
